We would be happy to cover any expenses we can related to travel and living costs and of course all research-related expenditures. Also, if we can assist any research groups working on similar topics to our lab with any experiments that need completion, please let us know.

Thanks to Laurence Pearl 🔥💚🚣‍♀️🛶♊️ for the idea - please copy it as we have

Very excited to announce that Kapil Gupta Dr Kapil Gupta has joined the #Imophoron team as a Senior Protein Scientist. He brings over 10 years experience as a protein biochemist and structural biologist. Welcome to the #team, Kapil!

Our CEO, Fred Garzoni met two other #Bristol based #FrancoBritish Young Leaders last night, Clare Siviter-Groschwald 🇪🇺 and Julia Cantel. Supporting #Bristol with pride as 2022's FrancoBritishCouncil Young Leaders. French Embassy UK🇫🇷🇪🇺

Pleased to announce that Mike Westby has joined Imophoron's board of directors. Mike has over 20 years experience in the #biotech and #pharma industry, including Pfizer, and we're very happy to have him on board!

We are looking for a talented Lab Mananger to support us in our exciting journey. Please spread the word! sciencecreates.livevacancies.co.uk/#/job/details/… #vaccines #Jobs

Huge congratulations to our co-founder, Imre Berger Berger Schaffitzel labs, who has been elected Fellow of Academy of Medical Sciences for his contributions to biomedical science & notable discoveries during the #COVID19 pandemic! 👏👏👏 bit.ly/3yKwUwP #AMSFellows2022 #uob

Today we want to say #congratulations to our junior protein scientist, Georgia Balchin, for attending her belated biochemistry MSci graduation ceremony. Georgia joined the team in March and we're excited to see what the future holds next for her #uob #MSci

We're thrilled to announce the formation of Imophoron's Scientific Advisory Board (SAB). The SAB is led by Imre Berger Berger Schaffitzel labs and consists of Adam Finn, Helen Bright, Bassam Hallis, Lisa Ng and Paul Edwards MBE. Read more 👉 bit.ly/3MV1NSy

Looking for the next step in your career? Come join us! We’re looking for a motivated and organized individual to join the Imophoron team as our admin and office manager. Read more and apply here: bit.ly/3dTBW1x

We are thrilled to introduce some of our #sponsors for #wvceu in #october. Watch the #video or head to vaccinenation.org/video/world-va… to find out more. #vaccinenation #sponsored

Our Co-founder and CEO Fred Garzoni is a confirmed speaker at the World Vaccine Congress 2022 (World Vaccine Congress). We are deligthed to sponsor the Showcase event. Meet us there! #WVCEU #vaccine

We are pleased to announce the appointment of Richard Bungay as Chief Executive Officer, to be based at the Company’s Bristol facility. Richard succeeds our founding #CEO, Fred Garzoni, who becomes Chief Scientific Officer. #CEO #news #Biotechnology 👉imophoron.com/copy-of-imopho…

I believe now in a brighter future when left in the hands of young entrepreneurs following the visit to Science Create incubators in Bristol with Hélène Duchêne and Minh-Hà Pham. Thank you Harry Destecroix and Frederic Garzoni for the presentation and warm welcome

Last week, we had the honour of hosting the French Ambassador to the UK, Her Excellency Hélène Duchêne accompanied by Minh-Hà Pham and Nada A. Harward. Thank you French Embassy UK🇫🇷🇪🇺, Ambascience UK, Science Creates, Fred Garzoni and Harry Destecroix for making this happen. 🇫🇷🇬🇧

Our CSO Frédéric GARZONI and Franco British Young Leader attended the recent Franco-British Summit in Paris at the Élysée Palace on 10th March. He met with the French President Emmanuel Macron and UK Prime Minister Rishi Sunak #innovation #Health #Entrepreneurship

Today, Sky News interviewed our very own Harry Destecroix, Richard Bungay from Imophoron Ltd & Donna Gallagher from CytoSeek about their reactions to today's Budget, with an emphasis on R&D tax credits. It will be aired at 8pm this evening, link here: lnkd.in/dy49krB #budget

We are pleased to announce that our CSO Frédéric GARZONI is a confirmed speaker at The World Vaccine Congress in Washington. Fred’s talk “The ADDomer as a vaccine platform: a COVID case study and beyond” is scheduled for 5th April at 14:40 EST. World Vaccine Congress #vaccine #cso

Imophoron is delighted to announce that Global Brain Corporation, headquartered in Japan, has joined our investor syndicate as part of a £2.4m extension to our Seed financing round. ➡ lnkd.in/e7tuNGFM #development #biotech #vaccine